Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06263387
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-12-14
Brief Title:
Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia AML Patients Ineligible for Intensive Chemotherapy IC Treated With Venetoclax Azacitidine
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| AML Adult |
Keywords: